Free Republic

High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is low-dose anticoagulation. These are the significant findings from the large-scale international "FREEDOM" trial, led by Valentin Fuster, MD, Ph.D. Patients were not in the ICU or intubated, and approximately half of them had signs of COVID-19 impacting their lungs with acute respiratory distress syndrome (ARDS). Patients were randomized to receive doses of three different types of anticoagulants within 24-48 hours of being admitted to the hospital and followed for 30...

LONDON - The blood thinner may be to blame for the severity of Israeli Prime Minister Ariel Sharon's stroke, but his doctors should not be criticized for prescribing it, independent experts said Thursday. Sharon was fighting for his life in an Israeli hospital after seven hours of surgery to remove blood from the right side of his brain following a burst blood vessel, or hemorrhagic stroke. His doctors said they planned to keep him sedated for another 72 hours. Experts say his chances of recovery are slim. Experts agree that while the blood thinner, an anticoagulant called enoxaparin, did not...